Valproate in the treatment of epilepsy in girls and women of childbearing potential (Q26865670)

4

0 references

Torbjörn Tomson

1

object named as

Torbjörn Tomson

1 reference

8

Eugen Trinka

1 reference

3

Paul Boon

1 reference

Anthony Marson

2

1 reference

Athanasios Covanis

5

1 reference

Eija Gaily

6

1 reference

Reetta Kälviäinen

7

1 reference

language of work or name

1 reference

July 2015

1 reference

1 reference

56

1 reference

PubMed

issue

7

1 reference

PubMed

page(s)

1006-19

1 reference

Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse

PubMed

cites work

1 reference

Valproate and the risk for congenital malformations: Is formulation and dosage regime important?

21 January 2018

1 reference

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry

21 January 2018

1 reference

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

21 January 2018

1 reference

Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts

21 January 2018

1 reference

Comparative safety of antiepileptic drugs during pregnancy

21 January 2018

1 reference

Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.

21 January 2018

1 reference

Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy

21 January 2018

1 reference

Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers

21 January 2018

1 reference

Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

Antiepileptic drug use of women with epilepsy and congenital malformations in offspring

21 January 2018

1 reference

IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study

21 January 2018

1 reference

In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.

21 January 2018

1 reference

Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years

21 January 2018

1 reference

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years

21 January 2018

1 reference

Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism

21 January 2018

1 reference

Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.

21 January 2018

1 reference

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy

21 January 2018

1 reference

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

Time to 12-month remission and treatment failure for generalised and unclassified epilepsy

21 January 2018

1 reference

Multiple treatment comparisons in epilepsy monotherapy trials

21 January 2018

1 reference

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

21 January 2018

1 reference

A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy

21 January 2018

1 reference

Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.

21 January 2018

1 reference

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

21 January 2018

1 reference

Sodium valproate: monotherapy and polytherapy

21 January 2018

1 reference

When antiepileptic drugs aggravate epilepsy

21 January 2018

1 reference

Combined analysis of risk factors for SUDEP.

21 January 2018

1 reference

Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy.

21 January 2018

1 reference

Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention

21 January 2018

1 reference

Cause-specific mortality in adult epilepsy patients from Tyrol, Austria: hospital-based study

21 January 2018

1 reference

Cause-specific mortality among patients with epilepsy: results from a 30-year cohort study

21 January 2018

1 reference

Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.

21 January 2018

1 reference

Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood.

21 January 2018

1 reference

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009

21 January 2018

1 reference

Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood.

21 January 2018

1 reference

Absence epilepsy: early prognostic signs

21 January 2018

1 reference

Myoclonic epilepsy in infancy: an electroclinical study and long-term follow-up of 38 patients

21 January 2018

1 reference

Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide

21 January 2018

1 reference

Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood.

21 January 2018

1 reference

Long-term outcome of 32 children with encephalopathy with status epilepticus during sleep, or ESES syndrome

21 January 2018

1 reference

Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects

21 January 2018

1 reference

Treatment of mitochondrial disorders.

21 January 2018

1 reference

The pharmacologic treatment of Dravet syndrome

21 January 2018

1 reference

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

21 January 2018

1 reference